Outlook Therapeutics is shifting from regulatory achievement to execution, building the commercial and financial infrastructure for LYTENAVA’s planned U.S. launch before the end of 2026. The company ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Outlook includes a simple strikethrough feature, along with a double strikethrough option. However, Outlook on the web currently supports only simple strikethrough. In the mobile version of Outlook, ...

ASX-listed rare earths junior Vital Metals is set to double down in North America via the acquisition of two projects from Canada’s Quebec Previous Metals Corp. A government-owned research agency in ...